Key terms

About VEEV

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest VEEV news

Apr 09 8:15am ET Maintaining Hold on Veeva Systems Amid New Salesforce Competition and Market Uncertainty Apr 09 7:35am ET Oppenheimer Reaffirms Their Buy Rating on Veeva Systems (VEEV) Apr 09 6:26am ET Maintaining Leadership: Buy Rating Affirmed for Veeva Systems Amid Competitive Pressures Apr 09 5:50am ET Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Veeva Systems (VEEV) and Ultragenyx Pharmaceutical (RARE) Apr 03 5:20am ET Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and AbbVie (ABBV) Apr 02 8:30am ET Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV) and NewAmsterdam Pharma Company (NAMS) Apr 02 8:10am ET Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Moderna (MRNA) Apr 02 7:25am ET Truist Financial Reaffirms Their Hold Rating on Veeva Systems (VEEV) Apr 02 7:00am ET Analysts Are Bullish on These Healthcare Stocks: Shockwave Medical (SWAV), Veeva Systems (VEEV) Apr 02 5:45am ET Maintaining Buy on Veeva Systems Amid CFO Transition and Confident Financial Outlook Apr 02 5:31am ET Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Vertex Pharmaceuticals (VRTX) and Veeva Systems (VEEV) Apr 02 4:35am ET Veeva Systems: A Buy Rating Amidst CFO Transition, with a Stable and Promising Outlook Apr 02 3:36am ET Barclays Sticks to Their Buy Rating for Veeva Systems (VEEV) Apr 01 4:26pm ET Veeva Systems Announces CFO Transition and Financial Outlook Apr 01 4:19pm ET Veeva CFO Brent Bowman to leave company Mar 25 8:01am ET Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Amgen (AMGN) and Petiq (PETQ) Mar 20 4:55am ET Veeva management to meet with Oppenheimer Mar 19 3:38pm ET Veeva management to meet with Oppenheimer Mar 12 8:21am ET Veeva price target raised to $210 from $160 at Morgan Stanley Mar 05 6:19am ET Veeva price target raised to $250 from $232 at KeyBanc Mar 05 3:11am ET Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), ZimVie Inc (ZIMV) and Veeva Systems (VEEV) Mar 01 8:45am ET Veeva price target raised to $245 from $220 at Piper Sandler Mar 01 7:57am ET Veeva price target raised to $203 from $187 at Truist Mar 01 7:53am ET Veeva price target raised to $242 from $229 at Wells Fargo Mar 01 7:49am ET Stifel Nicolaus Keeps Their Buy Rating on Veeva Systems (VEEV) Mar 01 7:48am ET Veeva price target raised to $260 from $220 at Needham Mar 01 7:40am ET Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV) Mar 01 7:34am ET Veeva price target raised to $220 from $185 at Canaccord Mar 01 7:31am ET Analysts Are Bullish on Top Healthcare Stocks: Veeva Systems (VEEV), Xenon (XENE) Mar 01 7:00am ET Veeva price target raised to $251 from $245 at Baird Mar 01 6:35am ET Buy Rating Affirmed: Veeva Systems’ Strong Q4 Results and Positive Long-Term Growth Outlook

No recent press releases are available for VEEV

VEEV Financials

1-year income & revenue

Key terms

VEEV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

VEEV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms